Background Upper respiratory samples for SARS-CoV-2 detection include the gold
standard nasopharyngeal (NP) swab, and mid-turbinate (MT) nasal swabs, oropharyngeal (OP) …

Rapid antigen tests (RATs) have become an invaluable tool for combating the COVID-19
pandemic. However, concerns have been raised regarding the ability of existing RATs to …

Detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is essential
for diagnosis, treatment, and infection control. Polymerase chain reaction (PCR) fails to …

Traditional cellular and live-virus methods for detection of SARS-CoV-2 neutralizing antibodies
(nAbs) are labor- and time-intensive, and thus not suited for routine use in the clinical lab …

Limited data highlight the need to understand differences in SARS-CoV-2 omicron (B.1.1.529)
variant viral load between the gold standard nasopharyngeal (NP) swab, mid-turbinate (…

Immunocompromised patients with prolonged coronavirus disease 2019 symptoms present
diagnostic and therapeutic challenges. We measured viral nucleocapsid antigenemia in 3 …

Introduction Swab pooling may allow for more efficient use of point-of-care assays for SARS-CoV-2
detection in settings where widespread testing is warranted, but the effects of pooling …

Viability of saliva samples stored for longer than 28 days has not been reported in the literature.
The COVID-19 pandemic has spawned new research evaluating various sample types, …

Prior literature has established a positive association between sickle cell disease and risk of
contracting SARS-CoV-2. Data from a cross-sectional study evaluating COVID-19 testing …

SARS-CoV-2, the causal agent of the global COVID-19 pandemic, made its appearance at
the end of 2019 and is still circulating in the population. The pandemic led to an urgent need …